Breadcrumb Home Technology January 10, 2018 12:00 AM News from other sources Modern Healthcare Tweet Share Share Email More Print PharmaceuticalsTrump likes drug price negotiations; his nominee for health secretary doesn't | The New York TimesAlex Azar isn't in favor of the government negotiating drug prices for Medicare beneficiaries, but he's more willing to consider negotiations for Part B drugs.U.S. pharma executives expect deals to pick up after tax overhaul | ReutersExecutives from large pharmaceuticals think the drug industry will undergo consolidation, given the recent tax deal, which lowers the corporate income tax.Information technologyState approves $151M EHR alignment at University of Vermont Health Network | Fierce HealthcareThe University of Vermont Health Network will implement a new EHR, moving four of its six hospitals to Epic over the next six years.CES 2018: Running list of digital health products | MobihealthnewsAmong the introductions at CES are a sleep-tracking headband from Philips and a vitamin-pushing water bottle.In other newsFallout from "nuclear button" tweets: jump in sales of radiation drug | NPRAfter Donald Trump tweeted that his "nuclear button" is bigger than Kim Jong Un's, sales of potassium iodide, which protects against radiation poisoning, have soared. The compound is commonly added to salt to iodize it. Letter to the Editor Send us a letter Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print. Recommended for You FDA approves first COVID-19 drug: antiviral remdesivir COVID test sales don't tell the whole story at Abbott Labs Sponsored Content View the discussion thread.